vs
SELECT MEDICAL HOLDINGS CORP（SEM）与威德福国际（WFRD）财务数据对比。点击上方公司名可切换其他公司
SELECT MEDICAL HOLDINGS CORP的季度营收约是威德福国际的1.2倍（$1.4B vs $1.2B），威德福国际净利率更高（9.5% vs 1.4%，领先8.0%），SELECT MEDICAL HOLDINGS CORP同比增速更快（6.4% vs -8.3%），威德福国际自由现金流更多（$85.0M vs $5.2M），过去两年SELECT MEDICAL HOLDINGS CORP的营收复合增速更高（2.8% vs -9.5%）
Select Medical是总部位于美国宾夕法尼亚州的医疗健康企业，业务涵盖长期急症护理、住院康复医院运营，同时开设有职业健康与物理治疗诊所，母公司Select Medical Holdings在纽约证券交易所挂牌上市。
威德福国际是一家美国跨国油田服务企业，总部位于美国，业务覆盖全球75个国家的油气产区，为油气井的钻探、评估、完井、生产及修井作业提供专业技术设备与相关服务，在全球油田服务领域拥有广泛布局。
SEM vs WFRD — 直观对比
营收规模更大
SEM
是对方的1.2倍
$1.2B
营收增速更快
SEM
高出14.7%
-8.3%
净利率更高
WFRD
高出8.0%
1.4%
自由现金流更多
WFRD
多$79.8M
$5.2M
两年增速更快
SEM
近两年复合增速
-9.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.2B |
| 净利润 | $20.2M | $109.0M |
| 毛利率 | — | — |
| 营业利润率 | 4.6% | 10.7% |
| 净利率 | 1.4% | 9.5% |
| 营收同比 | 6.4% | -8.3% |
| 净利润同比 | 225.7% | -21.6% |
| 每股收益（稀释后） | $0.17 | $1.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SEMWFRD
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.4B | $1.3B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.3B | $1.3B | ||
| Q3 24 | $1.3B | $1.4B | ||
| Q2 24 | $1.3B | $1.4B |
净利润SEMWFRD
| Q1 26 | — | $109.0M | ||
| Q4 25 | $20.2M | $138.0M | ||
| Q3 25 | $28.8M | $81.0M | ||
| Q2 25 | $40.6M | $136.0M | ||
| Q1 25 | $56.7M | $76.0M | ||
| Q4 24 | $-16.1M | $112.0M | ||
| Q3 24 | $55.6M | $157.0M | ||
| Q2 24 | $77.6M | $125.0M |
营业利润率SEMWFRD
| Q1 26 | — | 10.7% | ||
| Q4 25 | 4.6% | 15.4% | ||
| Q3 25 | 5.4% | 14.4% | ||
| Q2 25 | 6.5% | 19.7% | ||
| Q1 25 | 8.3% | 11.9% | ||
| Q4 24 | 1.6% | 14.8% | ||
| Q3 24 | 4.3% | 17.2% | ||
| Q2 24 | 5.8% | 18.8% |
净利率SEMWFRD
| Q1 26 | — | 9.5% | ||
| Q4 25 | 1.4% | 10.7% | ||
| Q3 25 | 2.1% | 6.6% | ||
| Q2 25 | 3.0% | 11.3% | ||
| Q1 25 | 4.2% | 6.4% | ||
| Q4 24 | -1.2% | 8.4% | ||
| Q3 24 | 4.4% | 11.1% | ||
| Q2 24 | 6.1% | 8.9% |
每股收益（稀释后）SEMWFRD
| Q1 26 | — | $1.49 | ||
| Q4 25 | $0.17 | $1.91 | ||
| Q3 25 | $0.23 | $1.12 | ||
| Q2 25 | $0.32 | $1.87 | ||
| Q1 25 | $0.44 | $1.03 | ||
| Q4 24 | $-0.12 | $1.53 | ||
| Q3 24 | $0.43 | $2.06 | ||
| Q2 24 | $0.60 | $1.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.5M | $1.0B |
| 总债务越低越好 | $1.8B | $1.5B |
| 股东权益账面价值 | $1.7B | $1.8B |
| 总资产 | $5.9B | — |
| 负债/权益比越低杠杆越低 | 1.06× | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资SEMWFRD
| Q1 26 | — | $1.0B | ||
| Q4 25 | $26.5M | $987.0M | ||
| Q3 25 | $60.1M | $967.0M | ||
| Q2 25 | $52.3M | $943.0M | ||
| Q1 25 | $53.2M | $873.0M | ||
| Q4 24 | $59.7M | $916.0M | ||
| Q3 24 | $191.5M | $920.0M | ||
| Q2 24 | $111.2M | $862.0M |
总债务SEMWFRD
| Q1 26 | — | $1.5B | ||
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $1.7B | $1.5B | ||
| Q2 25 | $1.8B | $1.6B | ||
| Q1 25 | $1.8B | $1.6B | ||
| Q4 24 | $1.7B | $1.6B | ||
| Q3 24 | $3.1B | $1.6B | ||
| Q2 24 | $3.6B | $1.6B |
股东权益SEMWFRD
| Q1 26 | — | $1.8B | ||
| Q4 25 | $1.7B | $1.7B | ||
| Q3 25 | $1.7B | $1.6B | ||
| Q2 25 | $1.7B | $1.5B | ||
| Q1 25 | $1.7B | $1.4B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.9B | $1.3B | ||
| Q2 24 | $1.4B | $1.2B |
总资产SEMWFRD
| Q1 26 | — | — | ||
| Q4 25 | $5.9B | $5.2B | ||
| Q3 25 | $5.7B | $5.3B | ||
| Q2 25 | $5.7B | $5.1B | ||
| Q1 25 | $5.7B | $5.1B | ||
| Q4 24 | $5.6B | $5.2B | ||
| Q3 24 | $8.0B | $5.2B | ||
| Q2 24 | $7.9B | $5.1B |
负债/权益比SEMWFRD
| Q1 26 | — | 0.84× | ||
| Q4 25 | 1.06× | 0.86× | ||
| Q3 25 | 1.03× | 0.94× | ||
| Q2 25 | 1.10× | 1.04× | ||
| Q1 25 | 1.03× | 1.17× | ||
| Q4 24 | 1.01× | 1.26× | ||
| Q3 24 | 1.62× | 1.21× | ||
| Q2 24 | 2.54× | 1.33× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $64.3M | $136.0M |
| 自由现金流经营现金流 - 资本支出 | $5.2M | $85.0M |
| 自由现金流率自由现金流/营收 | 0.4% | 7.4% |
| 资本支出强度资本支出/营收 | 4.2% | 4.7% |
| 现金转化率经营现金流/净利润 | 3.19× | 1.25× |
| 过去12个月自由现金流最近4个季度 | $117.2M | $470.0M |
8季度趋势，按日历期对齐
经营现金流SEMWFRD
| Q1 26 | — | $136.0M | ||
| Q4 25 | $64.3M | $268.0M | ||
| Q3 25 | $175.3M | $138.0M | ||
| Q2 25 | $110.3M | $128.0M | ||
| Q1 25 | $-3.5M | $142.0M | ||
| Q4 24 | $125.4M | $249.0M | ||
| Q3 24 | $181.0M | $262.0M | ||
| Q2 24 | $278.2M | $150.0M |
自由现金流SEMWFRD
| Q1 26 | — | $85.0M | ||
| Q4 25 | $5.2M | $217.0M | ||
| Q3 25 | $122.2M | $94.0M | ||
| Q2 25 | $45.6M | $74.0M | ||
| Q1 25 | $-55.8M | $65.0M | ||
| Q4 24 | $62.0M | $149.0M | ||
| Q3 24 | $130.3M | $184.0M | ||
| Q2 24 | $222.6M | $88.0M |
自由现金流率SEMWFRD
| Q1 26 | — | 7.4% | ||
| Q4 25 | 0.4% | 16.8% | ||
| Q3 25 | 9.0% | 7.6% | ||
| Q2 25 | 3.4% | 6.1% | ||
| Q1 25 | -4.1% | 5.4% | ||
| Q4 24 | 4.7% | 11.1% | ||
| Q3 24 | 10.2% | 13.1% | ||
| Q2 24 | 17.4% | 6.3% |
资本支出强度SEMWFRD
| Q1 26 | — | 4.7% | ||
| Q4 25 | 4.2% | 4.0% | ||
| Q3 25 | 3.9% | 3.6% | ||
| Q2 25 | 4.8% | 4.5% | ||
| Q1 25 | 3.9% | 6.5% | ||
| Q4 24 | 4.8% | 7.5% | ||
| Q3 24 | 4.0% | 5.5% | ||
| Q2 24 | 4.3% | 4.4% |
现金转化率SEMWFRD
| Q1 26 | — | 1.25× | ||
| Q4 25 | 3.19× | 1.94× | ||
| Q3 25 | 6.09× | 1.70× | ||
| Q2 25 | 2.72× | 0.94× | ||
| Q1 25 | -0.06× | 1.87× | ||
| Q4 24 | — | 2.22× | ||
| Q3 24 | 3.25× | 1.67× | ||
| Q2 24 | 3.59× | 1.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
WFRD
| Middle East/North Africa/Asia | $556.0M | 48% |
| Other | $360.0M | 31% |
| Europe/Sub-Sahara Africa/Russia | $236.0M | 20% |
